What Phase 1 Clinical Trials Evaluate
Phase 1 clinical trials are the first step in evaluating an investigational drug in people. These studies help researchers learn how the body responds to a potential treatment and begin to identify an appropriate dosage range for future research. Early-phase studies focus on safety, tolerability, and how the investigational drug behaves in the body. All study procedures follow approved protocols and include close monitoring by trained clinical staff.
Phase 1A Studies: Healthy Volunteers
Phase 1A studies usually involve healthy volunteers. These initial studies help researchers evaluate early safety and identify an appropriate dosage range for the investigational drug. Depending on the study design, participation may include outpatient visits or monitored overnight stays. Assessments such as vital signs, laboratory work, and observation periods are performed according to the study protocol to help researchers understand how the investigational drug behaves in the body.
Phase 1B Studies: Individuals With the Target Condition
Phase 1B studies often involve confirming dosage levels identified in Phase 1A — this time in individuals with the target condition. These studies provide additional early-phase safety and pharmacologic information. Participants take part in study-related evaluations as outlined in the research protocol, with clinical staff available throughout the process for monitoring and support.
Why Join a Clinical Trial
Why Participants Choose Equity Medical
We believe clinical research should be compassionate, transparent, and easy to access. With flexible scheduling, clear communication, and support from our clinical team, we work to ensure your experience is informative and respectful.
Our Bronx, NY, and Bowling Green, KY research centers include on-site pharmacies and laboratories, overnight rooms, private showers, and entertainment areas. These features help support the requirements of Phase 1A and Phase 1B studies.
